Last reviewed · How we verify

NCT07323823: PBM

The Effect of PBM on the Electrical Activity of the Brain in Stroke Patients

Not yet recruiting NA Last updated 7 January 2026
What this trial tests

NA trial testing photobiomodulation (PBM) in Post-stroke Aphasia in 66 participants. Not yet recruiting.

Timeline
31 December 2025
Primary endpoint
31 December 2026
31 December 2026

Quick facts

Lead sponsorPusan National University Yangsan Hospital
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingnone
Primary purposetreatment
Enrollment66
Start date31 December 2025
Primary completion31 December 2026
Estimated completion31 December 2026

Drugs / interventions tested

Conditions studied

Sponsor

Pusan National University Yangsan Hospital

Who can join

Adults 18 to 80, any sex, with Post-stroke Aphasia. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The Effect of Low-Level Light Therapy on the Electrical Activity of the Brain in Stroke Patients

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Post-stroke Aphasia

Currently open trials in the same condition.

Other Pusan National University Yangsan Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07323823.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing